
Lawsuits against Bayer are on the rise over claims that the company’s weedkiller causes cancer. The legal cases have taken a toll on Bayer’s share price and reputation.
More than 42,000 plaintiffs have joined lawsuits against German chemical giant Bayer, blaming the company’s glyphosate-based weedkiller for their cancer.
The number of plaintiffs, largely brought by US citizens, is now at 42,700 — more than double the 18,400 reported in the middle of July, Bayer announced on Wednesday.
Read more: Bayer Monsanto damages reduced to $25.27 million by US judge
The legal cases all concern Roundup, a weedkiller with controversial active ingredient glyphosate.
“This significant increase is clearly driven by the plaintiff-side television advertising spend which is estimated to have roughly doubled in the third quarter compared with the entire first half of the year,” Bayer said in a statement.
“However, the number of lawsuits says nothing about their merits,” it added.
Read more: Germany set to ban glyphosate from end of 2023
Claims against the company gathered momentum following a lawsuit in August 2018 that found Monsanto, a Bayer subsidiary, should have warned of alleged cancer risks associated with its glyphosate-based weedkillers.
Bayer’s shares have dropped 30% since then.
[…] 31, 2019 DW No Comments This post was originally published on this […]
[…] 42,000 Plaintiffs Sue Bayer Over RoundUp Glyphosate Pesticide that Has Been Shown to Cause Cancer […]
[…] Bayer took on the legal burdens of Monsanto’s flagship product, Roundup, and now faces over 42,000 lawsuits just for Non Hodgkin’s Lymphoma alone. Thousands more await their turn to sue Monsanto, however, […]